Erhard Godehardt
University of Düsseldorf
112 Papers
1K Citations
Erhard Godehardt is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Medicine & Cyclosporin a. The author has an hindex of 32, co-authored 112 publications.
Chat about Author
Papers
Definition and prevalence of subfertility and infertility.
TL;DR: Under appropriate circumstances a basic infertility work-up after six unsuccessful cycles with fertility-focused intercourse will identify couples with significant infertility problems to avoid both infertility under- and over-treatment, regardless of age.
Time to pregnancy: results of the German prospective study and impact on the management of infertility
TL;DR: A non-parametric estimation of cumulative probabilities of conception (CPC) in natural family planning users illustrating an ideal of human fertility potential is presented, finding most couples conceive within six cycles with timed intercourse.
The risk of ischemic spinal cord injury in patients undergoing graft replacement for thoracoabdominal aortic aneurysms
Klaus Grabitz,Wilhelm Sandmann,Klaus Stühmeier,Bernd Mainzer,Erhard Godehardt,Barbara Ohle,Ursula Hartwich +6 more
TL;DR: The risk of ischemic spinal cord injury during replacement for TAA can be assessed continuously by monitoring the sSSEP directly from the spinal cord.
154
Final ART success rates: a 10 years survey
TL;DR: Most couples with infertility problems can be treated successfully if they continue treatment and ART can reach natural fertility rates, even with the restrictions in place as a result of the German Embryo Protection Law.
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Jost Hillenkamp,Thomas Reinhard,R. S. Ross,Daniel Böhringer,Olaf Cartsburg,Michael Roggendorf,Erik De Clercq,Erhard Godehardt,Rainer Sundmacher +8 more
TL;DR: In this article, the efficacy of cidofovir 1% eyedrops with and without cyclosporin A 1% eye drops as a treatment of acute adenoviral keratoconjunctivitis (AKC) was evaluated.
112